Ausgabe 5/2023
Inhalt (15 Artikel)
Capturing the Diversity of Dermatology—What’s in a Name?
Taylor Erickson, Karishma Daftary, Victor L. Quan, Raj Chovatiya
Targeting Inflammation in Acne: Current Treatments and Future Prospects
Sebastian Cruz, Natalia Vecerek, Nada Elbuluk
Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review
Jonathan K. Hwang, Jose W. Ricardo, Shari R. Lipner
Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis
Chia-Ling Yu, Po-Yi Chou, Chih-Sung Liang, Li-Huei Chiang, Tzu-Yu Wang, Yu-Kang Tu, Ching-Chi Chi
Atopic Dermatitis Across Shades of Skin
Victor L. Quan, Taylor Erickson, Karishma Daftary, Raj Chovatiya
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
Diana Bernardo, Thomas Bieber, Tiago Torres
Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies
Christopher J. Fay, Samantha Jakuboski, Beth Mclellan, Blair S. Allais, Yevgeniy Semenov, Cecilia A. Larocca, Nicole R. LeBoeuf
Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial
Elaine C. Siegfried, Michael J. Cork, Norito Katoh, Haixin Zhang, Chien-Chia Chuang, Ryan B. Thomas, Ana B. Rossi, Sonya L. Cyr, Annie Zhang
Association Between the Use of Topical Calcineurin Inhibitors and the Risk of Cancer Among Patients with Atopic Dermatitis: A Nationwide, Population-Based, Retrospective Cohort Study
Hao-Hsin Huang, Dereck Shen, Tom C. Chan, Yung-Tsu Cho, Chao-Hsiun Tang, Chia-Yu Chu
Apremilast Long-Term Safety Up to 5 Years from 15 Pooled Randomized, Placebo-Controlled Studies of Psoriasis, Psoriatic Arthritis, and Behçet’s Syndrome
Philip J. Mease, Gülen Hatemi, Maria Paris, Sue Cheng, Peter Maes, Wendy Zhang, Rebecca Shi, Andrea Flower, Hernan Picard, Linda Stein Gold
Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials
Michael Sticherling, Arjen F. Nikkels, Ashraf M. Hamza, Pearl Kwong, Jacek C. Szepietowski, Mahira El Sayed, Pierre-Dominique Ghislain, Alkes A. Khotko, Manmath Patekar, Christine-Elke Ortmann, Pascal Forrer, Philemon Papanastasiou, Deborah Keefe
Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study
Tadashi Terui, Yukari Okubo, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Natsuka Uehara, Takahiro Handa, Masayuki Tanaka, Wendy Zhang, Maria Paris, Masamoto Murakami
The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights
Kathy A. Fraser
Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”
Shurong Chen, Yi Chen
Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”
Chia-Ling Yu, Po-Yi Chou, Chih-Sung Liang, Li-Huei Chiang, Tzu-Yu Wang, Yu-Kang Tu, Ching-Chi Chi